Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Neurochem Int. 2016 Jun 14;99:72–84. doi: 10.1016/j.neuint.2016.06.009

Fig. 1. Geographic distribution of SSADHD patients (n=176).

Fig. 1

Afghanistan, Argentina, Taiwan, Canada, France, Lebanon, Bulgaria, Life (New Caledonia) (n=2 patients each). Malaysia, UAE (United Arab Emirates), Tunisia, Syria, Luxembourg, Inuit (Iceland), Uruguay, Yemen, Sweden, Denmark, Sicily, Albania, Algeria, Belgium (n=1 patient each; data taken from 36 publications).